Adverum Biotechnologies Depreciation & Amortization 2011-2026 | ADVM

Annual Depreciation & Amortization Adverum Biotechnologies

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.65 M	5.64 M	6.53 M	4.64 M	4.16 M	1.57 M	1.75 M	2.1 M	1.6 M	812 K	162 K	26 K	1 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.53 M	1 K	2.51 M

Quarterly Depreciation & Amortization Adverum Biotechnologies

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	683 K	-	-	997 K	-	-	1.59 M	-	4.82 M	3.03 M	1.42 M	-	3.32 M	2.36 M	1.17 M	-	1.2 M	1.3 M	599 K	-	400 K	400 K	426 K	-	400 K	500 K	459 K	-	500 K	600 K	516 K	-	400 K	300 K	320 K	-	241 K	147 K	118 K	-	49 K	25 K	9 K	-	7 K	7 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.82 M	7 K	885 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Alector ALEC	5.72 M	$ 2.11	-13.17 %	$ 217 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Apellis Pharmaceuticals APLS	1.56 M	$ 20.52	-2.12 %	$ 2.59 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Axsome Therapeutics AXSM	503 K	$ 164.13	0.15 %	$ 8.17 B	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aytu BioScience AYTU	5.38 M	$ 2.49	-3.11 %	$ 15.6 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
BridgeBio Pharma BBIO	5.43 M	$ 64.24	-3.37 %	$ 12.3 B	USA
BioAtla BCAB	1.22 M	$ 0.18	-26.92 %	$ 8.6 M	USA
BioCardia BCDA	84 K	$ 1.37	6.2 %	$ 29 M	USA
BioCryst Pharmaceuticals BCRX	1.25 M	$ 8.61	-1.66 %	$ 1.78 B	USA
Black Diamond Therapeutics BDTX	343 K	$ 2.4	-3.04 %	$ 132 M	USA
Beam Therapeutics BEAM	22.3 M	$ 28.29	-0.6 %	$ 2.8 B	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Biohaven Pharmaceutical Holding Company Ltd. BHVN	24.9 M	$ 11.47	-0.43 %	$ 742 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Biogen BIIB	780 M	$ 187.68	-2.16 %	$ 27.5 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
BioVie BIVI	229 K	$ 1.38	-0.01 %	$ 2.04 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
BioMarin Pharmaceutical BMRN	79.6 M	$ 60.68	-1.7 %	$ 11.6 B	USA
Bristol-Myers Squibb Company BMY	4.01 B	$ 62.54	0.27 %	$ 127 B	USA
Benitec Biopharma BNTC	66 K	$ 10.85	-0.5 %	$ 447 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
BioXcel Therapeutics BTAI	309 K	$ 1.63	-2.69 %	$ 4.13 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA